These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3471146)

  • 1. Activation of blood coagulation factor XIII.
    Lorand L
    Ann N Y Acad Sci; 1986; 485():144-58. PubMed ID: 3471146
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of fibrinogen and Ca2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII.
    Shafer JA; Lewis SD; Janus TJ; Lorand L
    Ann N Y Acad Sci; 1986; 485():134-9. PubMed ID: 3471144
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 4. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the effect of thrombin on macromolecular substrates].
    Sereiskaia AA; Strukova SM
    Dokl Akad Nauk SSSR; 1985; 282(2):481-4. PubMed ID: 4017865
    [No Abstract]   [Full Text] [Related]  

  • 7. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.
    Lewis SD; Lorand L; Fenton JW; Shafer JA
    Biochemistry; 1987 Dec; 26(24):7597-603. PubMed ID: 3427095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
    Trumbo TA; Maurer MC
    J Biol Chem; 2000 Jul; 275(27):20627-31. PubMed ID: 10801785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptospira Immunoglobulin-Like Protein B (LigB) Binds to Both the C-Terminal 23 Amino Acids of Fibrinogen αC Domain and Factor XIII: Insight into the Mechanism of LigB-Mediated Blockage of Fibrinogen α Chain Cross-Linking.
    Hsieh CL; Chang E; Tseng A; Ptak C; Wu LC; Su CL; McDonough SP; Lin YP; Chang YF
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004974. PubMed ID: 27622634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation.
    Trumbo TA; Maurer MC
    Biochemistry; 2002 Feb; 41(8):2859-68. PubMed ID: 11851434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conversion of fibrinogen to fibrin: A brief history of some key events.
    Doolittle RF
    Matrix Biol; 2017 Jul; 60-61():5-7. PubMed ID: 27519977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen.
    Krarup A; Gulla KC; Gál P; Hajela K; Sim RB
    Biochim Biophys Acta; 2008 Sep; 1784(9):1294-300. PubMed ID: 18456010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of plasma Factor XIII by acetylated thrombin].
    Orlova AS; Baskova IP
    Biokhimiia; 1977 Feb; 42(2):297-9. PubMed ID: 856308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-related regulatory function of fibrinogen.
    Credo RB; Curtis CG; Lorand L
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4234-7. PubMed ID: 279911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of anhydrothrombin and characterization of its interaction with natural thrombin substrates.
    Hosokawa K; Ohnishi T; Shima M; Nagata M; Koide T
    Biochem J; 2001 Mar; 354(Pt 2):309-13. PubMed ID: 11171108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.